Cyfuse Biomedical KK

48
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3311800001
JPY
560.00
19 (3.51%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Cyfuse Biomedical KK Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
Profit Before Tax
-869.00
-586.00
-471.00
144.00
-327.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-11.00
-22.00
-38.00
-7.00
-18.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-760.00
-562.00
-403.00
161.00
-294.00
Cash Flow from Investing Activities
-8.00
-19.00
-430.00
-50.00
0.00
Cash Flow from Financing Activities
-52.00
18.00
2,658.00
229.00
488.00
Net Cash Inflow / Outflow
-821.00
-563.00
1,824.00
340.00
194.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cyfuse Biomedical KK
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-869.747
-813.125
-56.00
-6.96%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-11.427
-74.983
63.00
84.76%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-760.553
-815.021
55.00
6.68%
Cash Flow from Investing Activities
-8.637
-0.279
-8.00
-2995.70%
Cash Flow from Financing Activities
-52.012
1121.527
-1,173.00
-104.64%
Net Cash Inflow / Outflow
-821.202
306.227
-1,127.00
-368.17%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -35.26% vs -39.32% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-760.55
-562.30
-35.26%